UNIVERSITETSSYKEHUSET NORD-NORGE HF
UNIVERSITETSSYKEHUSET NORD-NORGE HF is registered as a other business enterprise in accordance with special legislation in Tromsø, Troms with organisation number 983974899. The business is classified under general hospital activities (NACE 86.101). The company was incorporated in 2001 and has 9530 registered employees. The company's stated purpose is: “Yte gode og likeverdige spesialisthelsetjenester til alle som trenger det uavhengig av alder, kjønn, bosted, økonomi og etnisk bakgrunn samt legge til rette for forsking og undervisning på høyt nasjonalt og internasjonalt nivå tilpasset helseforetakets rolle som universitetsklinikk.”. The most recent filed accounts, for the 2025 financial year, show NOK 11.8bn in revenue and NOK 16.5m in operating profit.
Key figures · 2025
Financial health · 2025
Who owns UNIVERSITETSSYKEHUSET NORD-NORGE HF?
No shareholders are registered for UNIVERSITETSSYKEHUSET NORD-NORGE HF in open Norwegian sources. Shareholder data exists mainly for limited companies (AS/ASA).
Which companies does UNIVERSITETSSYKEHUSET NORD-NORGE HF own?
UNIVERSITETSSYKEHUSET NORD-NORGE HF holds stakes in 3 companies:
- PROPHYLIX PHARMA HOLDING AS 4.9%
- NORINNOVA AS 2.2%
- PROPHYLIX PHARMA HOLDING AS 0.8%
Frequently asked questions about UNIVERSITETSSYKEHUSET NORD-NORGE HF
What is the revenue of UNIVERSITETSSYKEHUSET NORD-NORGE HF?
UNIVERSITETSSYKEHUSET NORD-NORGE HF had revenue of NOK 11.8bn in 2025.
Who is the general manager of UNIVERSITETSSYKEHUSET NORD-NORGE HF?
David Johansen is registered as general manager of UNIVERSITETSSYKEHUSET NORD-NORGE HF.
Where is UNIVERSITETSSYKEHUSET NORD-NORGE HF based?
UNIVERSITETSSYKEHUSET NORD-NORGE HF has its business address in Tromsø.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.